Miniatura

Fitxers

648042.pdf (2.35 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2015-02-02

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/103446

Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1101/gr.180240.114

Resum

While analyzing the DNA methylome of multiple myeloma (MM), a plasma cell neoplasm, by whole-genome bisulfite sequencing and high-density arrays, we observed a highly heterogeneous pattern globally characterized by regional DNA hypermethylation embedded in extensive hypomethylation. In contrast to the widely reported DNA hypermethylation of promoter-associated CpG islands (CGIs) in cancer, hypermethylated sites in MM, as opposed to normal plasma cells, were located outside CpG islands and were unexpectedly associated with intronic enhancer regions defined in normal B cells and plasma cells. Both RNA-seq and in vitro reporter assays indicated that enhancer hypermethylation is globally associated with down-regulation of its host genes. ChIP-seq and DNase-seq further revealed that DNA hypermethylation in these regions is related to enhancer decommissioning. Hypermethylated enhancer regions overlapped with binding sites of B cell-specific transcription factors (TFs) and the degree of enhancer methylation inversely correlated with expression levels of these TFs in MM. Furthermore, hypermethylated regions in MM were methylated in stem cells and gradually became demethylated during normal B-cell differentiation, suggesting that MM cells either reacquire epigenetic features of undifferentiated cells or maintain an epigenetic signature of a putative myeloma stem cell progenitor. Overall, we have identified DNA hypermethylation of developmentally regulated enhancers as a new type of epigenetic modification associated with the pathogenesis of MM.

Matèries

Mielomatosi, ADN, Cèl·lules B, Epigènesi

Matèries (anglès)

Myeloproliferative disorders, DNA, B cells, Epigenesis

Citació

Col·leccions

Articles publicats en revistes (Fonaments Clínics)

Citació

AGIRRE, Xabier, CASTELLANO, Giancarlo, PASCUAL, Marien, HEATH, Simon c., KULIS, Marta, SEGURA, Victor, BERGMANN, Anke, ESTEVE CODINA, Anna, MERKEL, Angelika, RAINERI, Emanuele, AGUEDA CALPENA, Lídia, BLANC, Julie, RICHARDSON, David, CLARKE, Laura, DATTA, Avik, RUSSIÑOL, Nuria, QUEIRÓS, Ana c., BEEKMAN, Renée, RODRÍGUEZ MADOZ, Juan r., SAN JOSÉ-ENERIZ, Edurne, FANG, Fang, GUTIÉRREZ, Norma c., GARCÍA VERDUGO, José m., ROBSON, Michael i., SCHIRMER, Eric c., GURUCEAGA, Elisabeth, MARTENS, Joost h. a., GUT, Marta, CALASANZ, María josé, FLICEK, Paul, SIEBERT, Reiner, CAMPO GÜERRI, Elias, SAN MIGUEL, Jesús f., MELNICK, Ari, STUNNENBERG, Hendrik g., GUT, Ivo g., PROSPER, Felipe, MARTÍN-SUBERO, José ignacio. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers. _Genome Research_. 2015. Vol. 25, núm. 4, pàgs. 478-487. [consulta: 27 de gener de 2026]. ISSN: 1088-9051. [Disponible a: https://hdl.handle.net/2445/103446]

Exportar metadades

JSON - METS

Compartir registre